Lazard Asset Management LLC Biotechnology

Lazard Asset Management LLC

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
MGTX Meira G Tx Holdings PLC	$283M	$0 0.0% of portfolio	96	Q3 2024 Reduced 61.75%
NKTX Nkarta, Inc.	$114M	$0 0.0% of portfolio	129	Q3 2024 Reduced 59.05%
OCGN Ocugen, Inc.	$158M	$0 0.0% of portfolio	550	Q3 2024 Reduced 76.51%
PSTX Poseida Therapeutics, Inc.	$815M	$0 0.0% of portfolio	128	Q3 2024 Reduced 61.33%
PGEN Precigen, Inc.	$281M	$0 0.0% of portfolio	259	Q3 2024 Reduced 98.95%
PRQR Pro Qr Therapeutics N.V.	$158M	$0 0.0% of portfolio	103	Q3 2024 Reduced 62.68%
RGLS Regulus Therapeutics Inc.	$14.6M	$0 0.0% of portfolio	122	Q2 2024 New
RCKT Rocket Pharmaceuticals, Inc.	$813M	$0 0.0% of portfolio	30	Q3 2024 Reduced 61.54%
SANA Sana Biotechnology, Inc.	$613M	$0 0.0% of portfolio	132	Q3 2024 Reduced 60.0%
STOK Stoke Therapeutics, Inc.	$453M	$0 0.0% of portfolio	58	Q3 2024 Reduced 72.77%
TSHA Taysha Gene Therapies, Inc.	$73M	$0 0.0% of portfolio	154	Q3 2024 Reduced 57.92%
TNYA Tenaya Therapeutics, Inc.	$43M	$0 0.0% of portfolio	77	Q3 2024 Reduced 64.52%
TCRX T Scan Therapeutics, Inc.	$49.4M	$0 0.0% of portfolio	70	Q3 2024 Reduced 60.23%
VERV Verve Therapeutics, Inc.	$456M	$0 0.0% of portfolio	85	Q3 2024 Reduced 39.72%

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.